Lantronix director Auker receives 8,541 shares
After the transaction, director James Chris Auker directly held 27,468 Lantronix common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lantronix Inc. (LTRX) director James Chris Auker reported the vesting of 8,541 restricted stock units, with 8,541 common shares issued on November 2, 2026. He directly held 27,468 common shares after the transaction. The RSUs convert into common stock on a one-for-one basis; they were granted on November 4, 2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F2, F3 | 8,541 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 8,541 | $0.00 | $0.00 |
Footnotes (3)
- F1. Represent shares of common stock issued upon the vesting of restricted stock units ("RSUs") granted on November 4, 2025 (the "Grant Date").
- F2. RSUs convert into common stock on a one-for-one basis.
- F3. The RSUs vest at the rate of one half (1/2) of the shares vesting six (6) months following the Grant Date and one half (1/2) of the shares vesting on the first anniversary of the Grant Date, such that the RSUs will be fully (100%) vested after one (1) year.
Key Figures
Key Terms
Restricted Stock Units financial
vesting financial
Grant Date technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the vesting schedule for James Chris Auker's LTRX RSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.